6i9bivnhsnyfqqadkfyo glycan

Glycan Therapeutics LLC

4 Orders Completed
Carrboro, North Carolina, US

About Glycan Therapeutics LLC

Glycan Therapeutics possesses a unique patented technology to synthesize heparin and heparan sulfate oligosaccharides for medical uses. Glycan Therapeutics (GT) is developing new drug therapies based on a novel synthetic carbohydrate technology platform. The platform technology can be used to synthesize an anticoagulant drug, like synthetic heparin, as well as design heparin-like oligosaccharides for research and development for other medical applications. We are the leader in the development of enzymatically synthesized sulfated oligosaccharides for a variety of indications. While aiming to develop a cost-effective method to prepare synthetic heparin, the company is also preparing a wide ranges of homogeneous heparin oligosaccharide products for researchers to investigate the role of these products in vascular biology, developmental biology and infectious diseases. The company has been supported by SBIR contracts from National Cancer Institute.

Our Services (11)


ic

Chemical Synthesis

Price on request

We are the leader in the synthesis of heparin sulfate oligosaccharides and oligosaccharide derivatives. We offer the highest quality products at an affordable price including: Custom synthesis of homogeneous heparin and heparin sulfate oligosaccharides with a wide range of sizes and sulfation patterns for your research needs.

  • Synthesis of oligosaccharides outside of the current catalog
  • Special large quantity synthesis, up to 10 g scale synthesis of pure oligosaccharides
  • Stable isotopically labeled oligosaccharides with 13C-, 2H- or both 13C- and 2H-labeled oligosaccharides as reference standards for Nuclear Magnetic Resonance (NMR) and mass spectrometry analysis. Customer can choose the saccharide residue that carries the 13C-label and 2H-label.
  • Introduction of fluorescent labels at the reducing end or nonreducing end of the oligosaccharides.
  • Introduction of affinity tag, like biotin, to the reducing end or nonreducing end of oligosaccharides.

milligram gram

ic

Oligosaccharide Synthesis

Price on request
Request a quote for more information about this service.

ic

Glycan Analysis

Price on request
Request a quote for more information about this service.

ic

Chemistry and Materials

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

ic

Computational Modeling

Price on request
Request a quote for more information about this service.

ic

Protein Sequencing

Price on request
Request a quote for more information about this service.

ic

Carbohydrate Services

Price on request
Request a quote for more information about this service.

ic

Synthetic Chemistry

Price on request
Request a quote for more information about this service.

ic

Data Services

Price on request
Request a quote for more information about this service.

ic

Biochemistry & Molecular Biology

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
JP

Jim Peterson

COO and Interim President

Glycan Therapeutics LLC has not received any reviews.

Glycan Therapeutics LLC has not received any endorsements.